The prospect of a fuel bill five times higher than last year has left already overstretched aid agencies worried they will be unable to help many of the hundreds of thousands of IDPs living in tents and shelters, just as winter approaches.
Trials of vaccines have already begun in the U.S., U.K., and Mali, and are beginning in Gabon, Germany, Kenya and Switzerland to determine safety, dosing and efficacy. Results from phase 1 clinical trials are expected to be available in December 2014.
Both academic research and practical experience shows that simply handing out traditional relief goods may not be the most effective way of helping the dispossessed.
Refugee children in the region suffer immensely as a result of conflict and displacement. The number of refugees has doubled in the last four years and more than half are children.